Selling And Administration Expenses 更改
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Insmed USD 93.1M 3.57M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Kyowa Hakko Kirin JPY 40.17B 3.59B 2024-03
Moderna USD 274M 196M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
PTC Therapeutics USD 73.27M 3.02M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Sarepta Therapeutics USD 127M 6.11M 2024-03
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03



Ultragenyx Pharmaceutical 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.